SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the Fifth Annual JMP Securities Healthcare Conference on Tuesday, September 28, 2010, at 8:30 a.m. Eastern Time at The New York Palace Hotel in New York City.
